glp-1 for diabetes type 2 Targeting GLP-1, GIP & GCG in Obesity and Research GLP-1 receptor agonists are increasingly

doi: 10.1161/CIRCULATIONAHA.124.067676

At night you can take some magnesium if you are feeling fatigue

Preclinical evidence In vivo studies utilizing the APP/PS1 mouse model of AD indicated neuroprotective properties of liraglutide

The schedule follows the standard pathway through 2mg and 4mg, then maintains at 8mg: Weeks 1-4: 2mg weekly Weeks 5-8: 4mg weekly Week 9+: 8mg weekly (maintenance) This reaches maintenance 4 weeks sooner than the 12mg protocol and avoids the final dose escalation that many researchers find most challenging

In most cases, dysesthesia events were mild and rarely led to treatment being stopped, but it is something prescribers will continue to monitor closely as further trial data becomes available